FIGHTING-OFF CORONAVIRUS (SARS-CoV-2) WITH BROAD-SPECTRUM ANTIVIRALS: ESTABLISHING ANIMAL VIRAL CHALLENGE MODEL

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Identification of those compounds that most efficiently prevent infection and disease in small animal model. Choice of compound and dosing regimen to be used in NHP

Task 110 To evaluate the ability of candidate antivirals to prevent or minimise SARSCoV2infection and disease in mice month 130Objective To identify those antivirals that most effectively prevent SARSCoV2 infection and disease symptoms in mice

Dissemination activity and quality report
Determine tropism in airway epithelia (months 9) and antiviral activity (month 12-18), M12

Determine tropism in airway epithelia (month 9) and antiviral activity (month 12-18)

Detailed characterization (IC50, IC90) of the antiviral activity of each identified inhibitor against MA SARS-CoV-2 and Omicron

Task 19 To confirm the efficacy of developed antivirals against cellfree and cellcell infection of a mouse adapted SARSCoV2 strain and VOCs month 2430Objectives To establish an infection model with a mouse adapted SARSCoV2 strain and to evaluate the antiviral activity of most promising SARSCoV2 inhibitors developed in the consortium

Characterization of antiviral tweezers: Preclinical assessment and dose-efficacy
Characterization of antiviral tweezers: Preclinical assessment and dose-efficacy, M12

Characterization of antiviral tweezers: Preclinical assessment and dose-efficacy

Determine tropism in airway epithelia (months 9) and antiviral activity (month 12-18)

Determine tropism in airway epithelia (month 9) and antiviral activity (month 12-18)

Report on implementation of a non-human primate model for SARS-CoV-2 infection and disease

Report on implementation of a non-human primate model for SARS-CoV-2 infection and disease.

MTT-based SARS-CoV-2 assay established
Determination of ability for antiviral to prevent disease and choice of dosing regimen to be used in NHP

Task 26 Objective To evaluate the ability for antivirals to prevent or minimise SARSCoV2induced disease in hamster month 2630Expected results To identify if a clinically relevant dosing regimen that can prevent SARSCoV2induced disease Such a dosing regimen can be further evaluated in NHPs

Optimised hamster model of SARS-CoV-2 for evaluation of antivirals

Task 25 Objective To optimise a small animal wildtype disease model of SARSCoV2 month 2425Expected results To decide a dose of SARSCoV2 that leads to measurable clinical symptoms but not severe disease

Establishing SOPs for in vitro evaluation of antiviral activity against SARS-CoV-2
Report of treatment efficacy and safety measures after treatment of SARS-CoV-2 infected NHP.

Report of treatment efficacy and safety measures after treatment of SARSCoV2 infected NHP

Publication list of primary research articles in high impact journals (R, PU)

Publication of primary research articles in high impact journals

GLP toxicity studies in rats after systemic and intranasal administration
Publication list of primary research articles in high impact journals (R, PU), M24

Publication of primary research articles in high impact journals

Characterization of the antiviral compound ssON: Preclinical assessment and dose-efficacy
Characterization of additional antiviral compounds made available to the consortium after starting the project: Preclinical assessment and dose-efficacy

Characterization of additional antiviral compounds made available to the consortium after starting the project Preclinical assessment and doseefficacy

Characterization antiviral polymers: Preclinical assessment and dose-efficacy
Characterization antiviral polymers: Preclinical assessment and dose-efficacy, M12

Characterization antiviral polymers: Preclinical assessment and dose-efficacy

List Public communication to specialized and general audiences, M24

Public dissemination to specialized and general audiences

List Public communication to specialized and general audiences

Public dissemination to specialized and general audiences

Publicaciones

BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults.

Autores: Seidel A, Zanoni M, Groß R, Krnavek D, Erdemci-Evin S, von Maltitz P, Albers DPJ, Conzelmann C, Liu S, Weil T, Mayer B, Hoffmann M, Pöhlmann S, Beil A, Kroschel J, Kirchhoff F, Münch J, Müller JA.
Publicado en: Frontiers Immunology, 2022, ISSN 1664-3224
Editor: Frontiers Media S.A
DOI: 10.3389/fimmu.2022.882918

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS-CoV-2 Spike

Autores: Batista AD, Rajpal S, Keitel B, Dietl S, Fresco-Cala B, Dinc M, Groß R, Sobek H, Münch J, Mizaikoff B
Publicado en: Adv Mater Interfaces, 2022, ISSN 2196-7350
Editor: Wiley
DOI: 10.1002/admi.202101925

Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.

Autores: Wettstein L, Immenschuh P, Weil T, Conzelmann C, Almeida-Hernández Y, Hoffmann M, Kempf A, Nehlmeier I, Lotke R, Petersen M, Stenger S, Kirchhoff F, Sauter D, Pöhlmann S, Sanchez-Garcia E, Münch J.
Publicado en: J Med Virol, 2022, ISSN 1096-9071
Editor: Wiley
DOI: 10.1002/jmv.28124

Molecular Tweezers - a new class of potent broad-spectrum antivirals against enveloped viruses.

Autores: E Taghuo K, M-H Le, T Schrader
Publicado en: Chemical Communications, 2022, ISSN 1359-7345
Editor: Royal Society of Chemistry
DOI: 10.1039/d1cc06737k

Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture

Autores: Wettstein, L., Knaff, P.M., Kersten,C., Müller,P., Weil, T., Conzelmann, C., Müller, J., Brückner, M., Hoffmann, M., Pöhlmann, S., Schirmeister, T., Münch, J., Mailänder, V
Publicado en: Communications Biology, 2022, ISSN 2399-3642
Editor: Nature
DOI: 10.1038/s42003-022-03613-4

SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses.

Autores: Lawrenz J, Xie Q, Zech F, Weil T, Seidel A, Krnavek D, van der Hoek L, Münch J, Müller JA, Kirchhoff F.
Publicado en: Clin Infect Dis, 2022, ISSN 1058-4838
Editor: University of Chicago Press
DOI: 10.1093/cid/ciac057

Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2

Autores: Toni Luise Meister, Yannick Brüggemann, Daniel Todt, Carina Conzelmann, Janis A Müller, Rüdiger Groß, Jan Münch, Adalbert Krawczyk, Jörg Steinmann, Jochen Steinmann, Stephanie Pfaender, Eike Steinmann
Publicado en: The Journal of Infectious Diseases, Edición 222/8, 2020, Página(s) 1289-1292, ISSN 0022-1899
Editor: University of Chicago Press
DOI: 10.1093/infdis/jiaa471

Detection of SARS-CoV-2 in human breastmilk

Autores: Rüdiger Groß, Carina Conzelmann, Janis A Müller, Steffen Stenger, Karin Steinhart, Frank Kirchhoff, Jan Münch
Publicado en: The Lancet, Edición 395/10239, 2020, Página(s) 1757-1758, ISSN 0140-6736
Editor: The Lancet Publishing Group
DOI: 10.1016/s0140-6736(20)31181-8

Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2

Autores: Groß R, Dias Loiola LM, Issmail L, Uhlig N, Eberlein V, Conzelmann C, Olari LR, Rauch L, Lawrenz J, Weil T, Müller JA, Cardoso MB, Gilg A, Larsson O, Höglund U, Pålsson SA, Tvilum AS, Løvschall KB, Kristensen MM, Spetz AL, Hontonnou F, Galloux M, Grunwald T, Zelikin AN*, Münch J*.
Publicado en: Adv. Sci., 2022, ISSN 2198-3844
Editor: Wiley
DOI: 10.1002/advs.202201378

Broad‐Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity

Autores: Alexander N. Zelikin, Francesco Stellacci
Publicado en: Advanced Healthcare Materials, Edición 10/6, 2021, Página(s) 2001433, ISSN 2192-2640
Editor: John Wiley and Sons Ltd
DOI: 10.1002/adhm.202001433

Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses.

Autores: Weil T, Kirupakaran A, Le MH, Rebmann P, Mieres-Perez J, Issmail L, Conzelmann C, Müller JA, Rauch L, Gilg A, Wettstein L, Groß R, Read C, Bergner T, Pålsson SA, Uhlig N, Eberlein V, Wöll H, Klärner FG, Stenger S, Kümmerer BM, Streeck H, Fois G, Frick M, Braubach P, Spetz AL, Grunwald T, Shorter J, Sanchez-Garcia E, Schrader T, Münch J.
Publicado en: JACS Au, 2022, ISSN 2691-3704
Editor: ACS Publications
DOI: 10.1021/jacsau.2c00220

Inhibitors of Activin Receptor-like Kinase 5 Interfere with SARS-CoV-2 S-Protein Processing and Spike-Mediated Cell Fusion via Attenuation of Furin Expression.

Autores: Mezger MC, Conzelmann C, Weil T, von Maltitz P, Albers DPJ, Münch J, Stamminger T, Schilling EM.
Publicado en: Viruses, 2022, Página(s) 1308, ISSN 1999-4915
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/v14061308

Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection

Autores: Sandra Axberg Pålsson, Aleksandra Dondalska, Joseph Bergenstråhle, Caroline Rolfes, Albin Björk, Laura Sedano, Ultan F. Power, Marie-Anne Rameix-Welti, Joakim Lundeberg, Marie Wahren-Herlenius, Peter Mastrangelo, Jean-Francois Eleouet, Ronan Le Goffic, Marie Galloux, Anna-Lena Spetz
Publicado en: Frontiers in Immunology, Edición 11, 2020, ISSN 1664-3224
Editor: Frontiers
DOI: 10.3389/fimmu.2020.580547

Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures

Autores: Desiree Schütz, Carina Conzelmann, Giorgio Fois, Rüdiger Groß, Tatjana Weil, Lukas Wettstein, Steffen Stenger, Alexander Zelikin, Thomas K. Hoffmann, Manfred Frick, Janis A. Müller, Jan Münch
Publicado en: American Journal of Physiology-Lung Cellular and Molecular Physiology, Edición 320/5, 2021, Página(s) L750-L756, ISSN 1040-0605
Editor: American Physiological Society
DOI: 10.1152/ajplung.00552.2020

Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA

Autores: Detlef Michel, Karin M. Danzer, Rüdiger Groß, Carina Conzelmann, Janis A. Müller, Axel Freischmidt, Jochen H. Weishaupt, Sandra Heller, Jan Münch, Manuela Michel, Thomas Stamminger, Alexander Kleger, Markus Otto
Publicado en: Journal of Virological Methods, Edición 286, 2020, Página(s) 113965, ISSN 0166-0934
Editor: Elsevier BV
DOI: 10.1016/j.jviromet.2020.113965

The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment

Autores: Wettstein L, Kirchhoff F, Münch J.
Publicado en: Int J Mol Sci, 2022, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms23031351

Nitric Oxide to Fight Viral Infections

Autores: Fabio Lisi, Alexander N. Zelikin, Rona Chandrawati
Publicado en: Advanced Science, Edición 8/7, 2021, Página(s) 2003895, ISSN 2198-3844
Editor: Wiley-VCH GmbH
DOI: 10.1002/advs.202003895

COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19.

Autores: Conforti A, Marra E, Palombo F, Roscilli G, Ravà M, Fumagalli V, Muzi A, Maffei M, Luberto L, Lione L, Salvatori E, Compagnone M, Pinto E, Pavoni E, Bucci F, Vitagliano G, Stoppoloni D, Pacello ML, Cappelletti M, Ferrara FF, D'Acunto E, Chiarini V, Arriga R, Nyska A, Di Lucia P, Marotta D, Bono E, Giustini L, Sala E, Perucchini C, Paterson J, Ryan KA, Challis AR, Matusali G, Colavita F, Caselli G
Publicado en: Mol Ther, 2021, ISSN 1525-0016
Editor: Nature Publishing Group
DOI: 10.1016/j.ymthe.2021.09.011

Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor.

Autores: Weil T, Lawrenz J, Seidel A, Münch J, Müller JA
Publicado en: Antiviral Res, 2022, ISSN 0166-3542
Editor: Elsevier BV
DOI: 10.1016/j.antiviral.2022.105343

Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell–Derived Intestinal Organoids

Autores: Jana Krüger, Rüdiger Groß, Carina Conzelmann, Janis A. Müller, Lennart Koepke, Konstantin M.J. Sparrer, Tatjana Weil, Desiree Schütz, Thomas Seufferlein, Thomas F.E. Barth, Steffen Stenger, Sandra Heller, Jan Münch, Alexander Kleger
Publicado en: Cellular and Molecular Gastroenterology and Hepatology, Edición 11/4, 2021, Página(s) 935-948, ISSN 2352-345X
Editor: Elsevier Inc.
DOI: 10.1016/j.jcmgh.2020.11.003

Towards the direct detection of viral materials at the surface of protective face masks via infrared spectroscopy.

Autores: Schorer V, Haas J, Stach R, Kokoric V, Groß R, Münch J, Hummel T, Sobek H, Mennig J, Mizaikoff B.
Publicado en: Sci Rep, 2022, ISSN 2045-2322
Editor: Nature Publishing Group
DOI: 10.1038/s41598-022-06335-z

Robust and durable serological response following pediatric SARS-CoV-2 infection

Autores: Renk H, Dulovic A, Seidel A, Becker M, Fabricius D, Zernickel M, Junker D, Groß R, Müller J, Hilger A, Bode SFN, Fritsch L, Frieh P, Haddad A, Görne T, Remppis J, Ganzemueller T, Dietz A, Huzly D, Hengel H, Kaier K, Weber S, Jacobsen EM, Kaiser PD, Traenkle B, Rothbauer U, Stich M, Tönshoff B, Hoffmann GF, Müller B, Ludwig C, Jahrsdörfer B, Schrezenmeier H, Peter A, Hörber S, Iftner T, Mün
Publicado en: Nat Commun, 2022, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-021-27595-9

SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

Autores: Rayhane Nchioua, Dorota Kmiec, Janis A. Müller, Carina Conzelmann, Rüdiger Groß, Chad M. Swanson, Stuart J. D. Neil, Steffen Stenger, Daniel Sauter, Jan Münch, Konstantin M. J. Sparrer, Frank Kirchhoff
Publicado en: mBio, Edición 11/5, 2020, ISSN 2150-7511
Editor: American Society for Microbiology
DOI: 10.1128/mbio.01930-20

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

Autores: Pauline Maisonnasse, Jérémie Guedj, Vanessa Contreras, Sylvie Behillil, Caroline Solas, Romain Marlin, Thibaut Naninck, Andres Pizzorno, Julien Lemaitre, Antonio Gonçalves, Nidhal Kahlaoui, Olivier Terrier, Raphael Ho Tsong Fang, Vincent Enouf, Nathalie Dereuddre-Bosquet, Angela Brisebarre, Franck Touret, Catherine Chapon, Bruno Hoen, Bruno Lina, Manuel Rosa Calatrava, Sylvie van der Werf, Xavi
Publicado en: Nature, Edición 585/7826, 2020, Página(s) 584-587, ISSN 0028-0836
Editor: Nature Publishing Group
DOI: 10.1038/s41586-020-2558-4

Supramolecular Mechanism of Viral Envelope Disruption by Molecular Tweezers

Autores: Tatjana Weil, Rüdiger Groß, Annika Röcker, Kenny Bravo-Rodriguez, Christian Heid, Andrea Sowislok, My-Hue Le, Nelli Erwin, Mridula Dwivedi, Stephen M. Bart, Paul Bates, Lukas Wettstein, Janis A. Müller, Mirja Harms, Konstantin Sparrer, Yasser B. Ruiz-Blanco, Christina M. Stürzel, Jens von Einem, Sina Lippold, Clarissa Read, Paul Walther, Marco Hebel, Florian Kreppel, Frank-Gerrit Klärner, Ga
Publicado en: Journal of the American Chemical Society, Edición 142/40, 2020, Página(s) 17024-17038, ISSN 0002-7863
Editor: American Chemical Society
DOI: 10.1021/jacs.0c06400

An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection

Autores: Carina Conzelmann, Andrea Gilg, Rüdiger Groß, Desiree Schütz, Nico Preising, Ludger Ständker, Bernd Jahrsdörfer, Hubert Schrezenmeier, Konstantin M.J. Sparrer, Thomas Stamminger, Steffen Stenger, Jan Münch, Janis A. Müller
Publicado en: Antiviral Research, Edición 181, 2020, Página(s) 104882, ISSN 0166-3542
Editor: Elsevier BV
DOI: 10.1016/j.antiviral.2020.104882

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Autores: Markus Hoffmann, Prerna Arora, Rüdiger Groß, Alina Seidel, Bojan F. Hörnich, Alexander S. Hahn, Nadine Krüger, Luise Graichen, Heike Hofmann-Winkler, Amy Kempf, Martin S. Winkler, Sebastian Schulz, Hans-Martin Jäck, Bernd Jahrsdörfer, Hubert Schrezenmeier, Martin Müller, Alexander Kleger, Jan Münch, Stefan Pöhlmann
Publicado en: Cell, Edición 184/9, 2021, Página(s) 2384-2393.e12, ISSN 0092-8674
Editor: Cell Press
DOI: 10.1016/j.cell.2021.03.036

Antibody-mediated procoagulant platelets in SARS-CoV-2- vaccination associated immune thrombotic thrombocytopenia.

Autores: Althaus K, Möller P, Uzun G, Singh A, Beck A, Bettag M, Bösmüller H, Guthoff M, Dorn F, Petzold GC, Henkes H, Heyne N, Jumaa H, Kreiser K, Limpach C, Luz B, Maschke M, Müller JA, Münch J, Nagel S, Pötzsch B, Müller J, Schlegel C, Viardot A, Bäzner H, Wolf M, Pelzl L, Warm V, Willinek WA, Steiner J, Schneiderhan-Marra N, Vollherbst D, Sachs UJ, Fend F, Bakchoul T.
Publicado en: Haematologica, 2021, ISSN 0390-6078
Editor: Ferrata Storti Foundation
DOI: 10.3324/haematol.2021.279000

Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors

Autores: Jahrsdörfer B, Groß R, Seidel A, Wettstein L, Ludwig C, Schwarz T, Körper S, Rojewski M, Lotfi R, Weinstock C, Seifried E, Corman VM, Drosten C, Münch J, Schrezenmeier H.
Publicado en: J Immunol, 2021, ISSN 0022-1767
Editor: American Association of Immunologists
DOI: 10.4049/jimmunol.2100036

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination

Autores: Barros-Martins J, Hammerschmidt SI, Cossmann A, Odak I, Stankov MV, Morillas Ramos G, Dopfer-Jablonka A, Heidemann A, Ritter C, Friedrichsen M, Schultze-Florey C, Ravens I, Willenzon S, Bubke A, Ristenpart J, Janssen A, Ssebyatika G, Bernhardt G, Münch J, Hoffmann M, Pöhlmann S, Krey T, Bošnjak B, Förster R, Behrens GMN.
Publicado en: Nat Med, 2021, ISSN 1546-170X
Editor: Springer Nature
DOI: 10.1038/s41591-021-01449-9

Inhibition of Respiratory Syncytial Virus Infection by Small Non-Coding RNA Fragments

Autores: Pålsson SA, Sekar V, Kutter C, Friedländer MR, Spetz AL
Publicado en: Int. J. Mol. Sci., 2022, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms23115990

Pasteurization Inactivates SARS-CoV-2–Spiked Breast Milk

Autores: Carina Conzelmann, Rüdiger Groß, Toni Luise Meister, Daniel Todt, Adalbert Krawczyk, Ulf Dittmer, Steffen Stenger, Jan Münch, Eike Steinmann, Janis A. Müller, Stephanie Pfaender
Publicado en: Pediatrics, Edición 147/1, 2021, Página(s) e2020031690, ISSN 0031-4005
Editor: American Academy of Pediatrics
DOI: 10.1542/peds.2020-031690

SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

Autores: Janis A. Müller, Rüdiger Groß, Carina Conzelmann, Jana Krüger, Uta Merle, Johannes Steinhart, Tatjana Weil, Lennart Koepke, Caterina Prelli Bozzo, Clarissa Read, Giorgio Fois, Tim Eiseler, Julia Gehrmann, Joanne van Vuuren, Isabel M. Wessbecher, Manfred Frick, Ivan G. Costa, Markus Breunig, Beate Grüner, Lynn Peters, Michael Schuster, Stefan Liebau, Thomas Seufferlein, Steffen Stenger, Albrec
Publicado en: Nature Metabolism, Edición 3/2, 2021, Página(s) 149-165, ISSN 2522-5812
Editor: Springer Nature
DOI: 10.1038/s42255-021-00347-1

Salivary extracellular vesicles inhibit Zika virus but not SARS‐CoV‐2 infection

Autores: Carina Conzelmann, Rüdiger Groß, Min Zou, Franziska Krüger, André Görgens, Manuela O Gustafsson, Samir El Andaloussi, Jan Münch, Janis A. Müller
Publicado en: Journal of Extracellular Vesicles, Edición 9/1, 2020, Página(s) 1808281, ISSN 2001-3078
Editor: Taylor and Francis Online
DOI: 10.1080/20013078.2020.1808281

Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation

Autores: Xia S, Lan Q, Zhu Y, Wang C, Xu W, Li Y, Wang L, Jiao F, Zhou J, Hua C, Wang Q, Cai X, Wu Y, Gao J, Liu H, Sun G, Münch J, Kirchhoff F, Yuan Z, Xie Y, Sun F, Jiang S, Lu L.
Publicado en: Signal Transduct Target Ther., 2021, ISSN 2059-3635
Editor: Springer Nature
DOI: 10.1038/s41392-021-00712-2

Is There a Role for Immunoregulatory and Antiviral Oligonucleotides Acting in the Extracellular Space? A Review and Hypothesis

Autores: Dondalska A, Axberg Pålsson S, Spetz AL
Publicado en: Int J Mol Sci, 2022, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms232314593

Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.

Autores: Groß R, Zanoni M, Seidel A, Conzelmann C, Gilg A, Krnavek D, Erdemci-Evin S, Mayer B, Hoffmann M, Pöhlmann S, Liu W, Hahn BH, Beil A, Kroschel J, Jahrsdörfer B, Schrezenmeier H, Kirchhoff F, Münch J, Müller JA.
Publicado en: EBioMedicine, 2022, ISSN 2352-3964
Editor: Elsevier BV
DOI: 10.1016/j.ebiom.2021.103761

High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection.

Autores: Jacobsen EM, Fabricius D, Class M, Topfstedt F, Lorenzetti R, Janowska I, Schmidt F, Staniek J, Zernickel M, Stamminger T, Dietz AN, Zellmer A, Hecht M, Rauch P, Blum C, Ludwig C, Jahrsdörfer B, Schrezenmeier H, Heeg M, Mayer B, Seidel A, Groß R, Münch J, Kirchhoff F, Bode SFN, Strauss G, Renk H, Elling R, Stich M, Voll RE, Tönshof B, Franz AR, Henneke P, Debatin KM, Rizzi M, Janda A.
Publicado en: Nature Communications, 2022, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-022-35055-1

The molecular tweezer CLR01 inhibits antibody-resistant cell-to-cell spread of human cytomegalovirus

Autores: S. Brenner, B. Braun, C. Read, T. Weil, P. Walther, T. Schrader, J. Münch, J. von Einem
Publicado en: Viruses, 2021, ISSN 1999-4915
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/v13091685

Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection

Autores: Lukas Wettstein, Tatjana Weil, Carina Conzelmann, Janis A. Müller, Rüdiger Groß, Maximilian Hirschenberger, Alina Seidel, Susanne Klute, Fabian Zech, Caterina Prelli Bozzo, Nico Preising, Giorgio Fois, Robin Lochbaum, Philip Maximilian Knaff, Volker Mailänder, Ludger Ständker, Dietmar Rudolf Thal, Christian Schumann, Steffen Stenger, Alexander Kleger, Günter Lochnit, Benjamin Mayer, Yasser B
Publicado en: Nature Communications, Edición 12/1, 2021, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-021-21972-0

Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19

Autores: Carina Conzelmann, Janis A Müller, Lukas Perkhofer, Konstantin MJ Sparrer, Alexander N Zelikin, Jan Münch, Alexander Kleger
Publicado en: Clinical Medicine, Edición 20/6, 2020, Página(s) e218-e221, ISSN 1470-2118
Editor: Royal College of Physicians
DOI: 10.7861/clinmed.2020-0351

IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.

Autores: Prelli Bozzo C, Nchioua R, Volcic M, Koepke L, Krüger J, Schütz D, Heller S, Stürzel CM, Kmiec D, Conzelmann C, Müller J, Zech F, Braun E, Groß R, Wettstein L, Weil T, Weiß J, Diofano F, Rodríguez Alfonso AA, Wiese S, Sauter D, Münch J, Goffinet C, Catanese A, Schön M, Boeckers TM, Stenger S, Sato K, Just S, Kleger A, Sparrer KMJ, Kirchhoff F.
Publicado en: Nat Comm, 2021, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-021-24817-y

Derechos de propiedad intelectual

SINGLE STRANDED OLIGONUCLEOTIDES INHIBITING ENDOCYTOSIS

Número de solicitud/publicación: 20 18074032
Fecha: 2018-09-06
Solicitante(s): STOCKHOLMS UNIVERSITET

NEW MOLECULAR TWEEZERS AGAINST NEUROLOGICAL DISORDERS AND VIRAL INFECTIONS

Número de solicitud/publicación: 19 824953
Fecha: 2019-06-28
Solicitante(s): UNIVERSITAET DUISBURG-ESSEN

SINGLE-STRANDED OLIGONUCLEOTIDES FOR USE IN THE MEDICAL TREATMENT AND/OR PROPHYLAXIS OF VIRUS INFECTIONS

Número de solicitud/publicación: 20 22061404
Fecha: 2022-04-28
Solicitante(s): STOCKHOLMS UNIVERSITET

Buscando datos de OpenAIRE...

Resultado final

Publicaciones

Derechos de propiedad intelectual

Compartir esta página Compartir esta página en las redes sociales

Descargar Descargar el contenido de la página